silver has been researched along with dolutegravir in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agostini, E; Cattelan, A; Gardin, S; Leoni, D; Mazzitelli, M; Mengato, D; Putaggio, C; Sasset, L; Scaglione, V; Trunfio, M; Vania, E | 1 |
1 other study(ies) available for silver and dolutegravir
| Article | Year |
|---|---|
Real-Life Experience on Dolutegravir and Lamivudine as Initial or Switch Therapy in a Silver Population Living with HIV.
Topics: Aged; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lamivudine; Male; Silver | 2023 |